Does chronic daily headache arise de novo in association with regular use of analgesics?

Headache

Volumn 43, Issue 3, 2003, Pages 179-190

  Bahra, Anish ^a   Walsh, Maggie ^b   Menon, Sanjeev ^c   Goadsby, Peter J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b Bognor Regis Hospital   (United Kingdom)

^c ST RICHARD S HOSPITAL   (United Kingdom)

Author keywords

Arthritis; Migraine; Tension type headache

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL;

ADULT; AGED; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEADACHE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; STANDARDIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ARTHRITIS; CROSS-SECTIONAL STUDIES; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RETROSPECTIVE STUDIES; TENSION-TYPE HEADACHE;

EID: 0037345772     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03041.x     Document Type: Article

References (50)

1. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular analgesic use [abstract]? Cephalalgia. 2000;20:294.
2. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: a field study of revised IHS criteria. Neurology. 1996;47:871-875.
3. Scher A, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497-506.
4. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;39:190-196.
5. Prencipe M, Casini AR, Ferretti C, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70:377-381.
6. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly. Prevalence, risk factors and biannual follow-up. Neurology. 2000;54:314-319.
7. Welch KM, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol. 2002;15:287-295.
8. Gowers WR. A Manual of Diseases of the Nervous System. Philadelphia, Pa: Blakiston, Son & Co; 1888.
9. Wolfson WQ, Graham JR. Development of tolerance to ergot alkaloids in a patient with unusually severe migraine. N Engl J Med. 1949;241:296-298.
10. Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin. 1951;26:153-161.
11. Friedman AP, Brazil P. Ergotamine tolerance in patients with migraine. JAMA. 1955;157:881-884.
12. Saper JR, Jones JM. Ergotamine tartrate dependency: features and possible mechanisms. Neuropharmacology. 1986;9:244-256.
13. Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine - a review and European consensus. Brain. 2000;123:9-18.
14. Kaube H, May A, Diener HC, Pfaffenrath V. Sumatriptan misuse in daily chronic headache [abstract]. BMJ. 1994;308:1573-1574.
15. Limmroth V, Kazarawa S, Fritsche G, Diener HC. Headache after frequent use of new serotonin agonists zolmitriptan and naratriptan [abstract]. Lancet. 1999;353:378.
16. Catarci T, Lenzi GL, Cerbo R, Fieschi C. Sumatriptan and daily headache [abstract]. J Neurol Neurosurg Psychiatry. 1995;58:508.
17. Catarci T, Fiacco F, Argentino C, Sette G, Cerbo R. Ergotamine-induced headache can be sustained by sumatriptan daily intake [abstract]. Cephalalgia. 1994;14:374-375.
18. Gobel H, Heinze A, Dworschak M. Easy therapeutical management of sumatriptan-induced daily headache [abstract]. Neurology. 1996;47:297-298.
19. Diener HC, Dahlof CG. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KM, eds. The Headaches. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:871-877.
20. Collier J. Diseases of the nervous system. In: Price FW, ed. A Textbook of the Practice of Medicine. 1st ed. London: Hodder and Stoughton; 1922.
21. Mathew NT, Stubits E, Nigam M. Transformation of migraine into daily headache: analysis of factors. Headache. 1982;22:66-68.
22. Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M. Analgetika-induzierter Dauerkopfschmerz. Dtsch Med Wochensch. 1984;109:369-373.
23. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia. 1987;7:15-19.
24. Medina J, Diamond S. Drug dependency in patients with chronic headaches. Headache. 1977;17:12-14.
25. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache. 1996;36:14-19.
26. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo [abstract]. Headache. 1988;28:61-62.
27. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
28. Olesen J. Revision of the International Headache Classification. An interim report [abstract]. Cephalalgia. 2001;21:261.
29. Anderson PG. Ergotamine headache. Headache. 1975;15:118-121.
30. Micieli G, Manzoni GC, Granella F, Martignoni E, Malferrari G, Nappi G. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M, eds. Drug-Induced Headache. Berlin: Springer-Verlag; 1988:20-28.
31. Saper JR. Ergotamine dependency - a review. Headache. 1987;27:435-438.
32. Scholz E, Diener HC, Geiselhart S, Wilkinson M. Drug-induced headache - does a critical dosage exist? In: Diener HC, ed. Drug-Induced Headache. Berlin: Springer-Verlag; 1988:29-43.
33. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after double-blind cessation of caffeine consumption. N Engl J Med. 1992;327:1109-1114.
34. van Dusseldorp M, Martijn BK. Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double-blind trial [abstract]. BMJ. 1990;300:1558-1559.
35. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache. 1990;30:634-638.
36. Silberstein SD, Silberstein JR. Chronic daily headache: long term prognosis following inpatient treatment with repetitive iv DHE. Headache. 1992;32:439-445.
37. Steiner TJ, Hering R. Abrupt withdrawal of medication in analgesic-abusing migraineurs [abstract]. Lancet. 1991;337:1442-1443.
38. Rapoport A, Weeks RE, Sheftell FD, Baskin SM, Verdi J. Analgesic rebound headache: theoretical and practical implications [abstract]. Cephalalgia. 1985;5(suppl 3):448-449.
39. Warner JS. Time required for improvement of an analgesic rebound headache. Headache. 1997;38:229-230.
40. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982;33:335-341.
41. Silberstein SD, Lipton RB. Chronic daily headache. In: Goadsby PJ, Silberstein SD, eds. Headache. New York: Butterworth-Heinemann; 1997:201-225.
42. Bowdler I, Kilian J. The association between analgesic abuse and headache - coincidental or causal [abstract]. Headache. 1988;28:494.
43. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001;41:303-309.
44. Abe T, Matsumoto K, Kuwazawa J, Toyoda I, Sasaki K. Headache associated with pituitary adenomas. Headache. 1998;38:782-786.
45. Levy MJ, Jager HR, Matharu MS, Goadsby PJ. Pituitary tumours and headache: does size matter? [abstract] Cephalalgia. 2002;22:592.
46. Lipton RB, Stewart WF, Cady R, et al. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000;40:783-791.
47. Mathew NT. Transformed or evolutional migraine [abstract]. Headache. 1987;27:305-306.
48. Pal B, Gibson C, Passmore J, Griffiths IF, Dick WC. A study of headaches and migraine in Sjogren's syndrome and other rheumatic disorders. Ann Rheum Dis. 1989;48:312-316.
49. Rasmussen BK, Jensen R, Schroll M. Epidemiology of headache in the general population: a prevalence study. J Clin Epidemiol. 1991;44:1147-1157.
50. Steiner TJ, Stewart WF, Kolodner K, Liberman J, Lipton RB. Epidemiology of migraine in England [abstract]. Cephalalgia. 1999;19:305-306.